Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

AIC-292 shows potent anti-HIV-1 activity in vivo and in first-in-human studies

Oct. 4, 2013

Valneva enters into license agreement with International AIDS Vaccine Initiative

Oct. 3, 2013

First demonstration of vaccine-mediated elimination of SIV infection

Oct. 3, 2013

New HIV integrase inhibitors disclosed by Bristol-Myers Squibb

Sep. 30, 2013

First approval in Europe for Gilead Sciences' cobicistat

Sep. 26, 2013

Profectus BioSciences begins phase I trial of HIV plasmid DNA vaccine

Sep. 19, 2013

Dolutegravir designated as orphan drug in Japan

Sep. 18, 2013

Researchers in China prepare new agents for HIV infection

Aug. 28, 2013

Toyama Chemical Co. presents novel products for HIV infection

Aug. 20, 2013

Canadian government provides funding to expand HIV antibody program

Aug. 14, 2013

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...